Title : Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin-induced apoptosis.

Pub. Date : 2019 Apr

PMID : 30883017






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, delanzomib enhanced the Dox-induced phosphorylation of p38/JNK and the expression of transcriptional target proteins of p53, such as p21, p27, NOXA, and PUMA. Doxorubicin tumor protein p53 Homo sapiens